The management of infections & sepsis in the immune-compromised host is challenging in many ways: delayed diagnosis, atypical presentation, metabolic changes, adjuvant therapies, severe prognosis, and end-of-life decisions. Sepsis is a common and mortal syndrome, and the incidence is increasing. On the other hand, mortality increases with pre-existing immunosuppression. Moreover, in the last decade, the immunosuppressed patient population and expected life is rising which exacerbated the issue. In low to middle-income countries, the infrastructure of hospitals makes the problem more complex. There is scarce information in the literature about the presentation and outcomes of sepsis in immunocompromised oncology patients with personalised management. Newer risk groups, associated with therapies (CAR-T) or older adults (immune-senescence) require specific attention. The new concept of pneumonia in the immunocompromised host provided an innovative management approach. An update of hot innovative topics with an approach led by international multidisciplinary experts will be provided.
Intended audience:
Medical doctors (e.g., trainees/residents and specialists in Infectious Diseases, Microbiology, Internal Medicine, and Public Health) pharmacists, nurses, and other healthcare professionals, who are interested in immunocompromised patients.
Objectives:
This course aims to review existing knowledge and discuss the subjects with experts with the aim of increasing insight and practical knowledge concerning the diagnosis and treatment of infections including prophylaxis in immunocompromised patients with a personalised management view. Participants will explore the challenges facing immunosuppressed patients such as difficult-to-treat infections, pneumonia, critical care, fungal infections and other Infection prevention & control issues. Attendees will get a detailed view of the determinants of sepsis and immune response in transplant patients, clinical microbiological diagnostic strategies and develop skills for caring for immunocompromised hosts.
Course coordinator:
Emine Alp Meşe, Ankara, Türkiye
Jordi Rello, Barcelona, Spain
Organisers:
Infectious Diseases and Clinical Microbiology Specialty Society of Türkiye (EKMUD) CIBERES, Instituto Salud Carlos III, Madrid, Spain
Accreditation:
ESCMID Office will apply for accreditation.
Certification:
Course organisers will monitor attendance. Only participants attending live sessions will be able to receive the certification.
Course Venue:
Susesi Congress Center, Antalya/Türkiye
Susesi Luxury Resort İskele Mevkii 07450 - Belek Antalya Website: www.susesihotel.com/en Accommodation: 3 nights 5-star luxury hotel-all inclusive: 660 Euros (incl. VAT). For further information, please contact ekmudkurs(at)valor.com.tr
Registration details:
The registration fee includes course material, 2 days of lunch, coffee and tea breaks. Travel costs are not included
Attendance Grant application
Attendance grant application is closed.